Pancreatic Cancer
- Colon, Lung, Other Digestive Organ, Pancreas, Phase IPhase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
- Colon, Esophagus, Larynx, Lip, Oral Cavity and Pharynx, Lung, Other Digestive Organ, Pancreas, Phase I, Rectum, Small Intestine, StomachA Study of TAK-188 in Adults With Advanced or Spreading Solid Tumors
- Esophagus, Other Digestive Organ, Pancreas, Phase I, Small Intestine, StomachA Phase 1 Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of BL-M05D1 in Subjects With Advanced or Metastatic Solid Tumors
- Esophagus, Liver, Other Digestive Organ, Pancreas, Small Intestine, StomachPhase II Prospective, Open Label Randomized Controlled Trial Comparing Standard of Care Therapy With and Without Sequential Cytoreductive Intervention for Patients With Metastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid (ctDNA) Levels
- Esophagus, Larynx, Lip, Oral Cavity and Pharynx, Lung, Other Urinary, Pancreas, Phase I, Urinary BladderA Phase 1 Open-label Study to Investigate PF-08046876 in Adult Participants With Advanced Solid Tumors